Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Integrated proteogenomic characterization of glioblastoma evolution

Cancer Cell(2024)10.1016/j.ccell.2023.12.015Source: DataRank Database

Integrated proteogenomic characterization of glioblastoma evolution is a research paper published in Cancer Cell (2024). On theSindex it has a DataRank of 0. It has been cited 95 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access95 citations

Download PDF

Cite:

Linked data & code

bioproject gen

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (9 grants)Impact (FWCI 27.28)OA: greenTopics (38)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (39)

Simona Migliozzi ORCID,Harim Koo ORCID,Jun-Hee Hong ORCID,Seung Min Park ORCID,Sooheon Kim

Live enrichment

PubMed:38215747 PMC:PMC10939876 OpenAlex:https://openalex.org/W4390739534

National Cancer Center

Grant: NCC-1810860

National Research Foundation of Korea

Grant: NRF-2021M3F7A1083230

National Research Foundation of Korea

Grant: NRF-2021R1A2C3013315

National Institutes of Health

Grant: R35CA253183

Institut National Du Cancer

Grant: INCA-DGOS-Inserm_12560

Ministry of Science, ICT and Future Planning

Grant: NCC-1810863

NCI NIH HHS

Grant: R01 CA268592

Korea Evaluation Institute of Industrial Technology

National Cancer Institute

FWCI

27.28

Citation Percentile

1.0%

Citation Trend

2024

2025

2026

greenLicense: http://www.elsevier.com/open-access/userlicense/1.0/

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC10939876/pdf/nihms-1954882.pdf

publisherhttps://api.elsevier.com/content/article/PII:S1535610823004439?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1535610823004439?httpAccept=text/plain

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/10939876

Fields of Study

Glioma Diagnosis and TreatmentMicrotubule and mitosis dynamicsCell Image Analysis Techniques

MeSH Terms

ProteogenomicsAnimalsBrain NeoplasmsDisease Models, AnimalGlioblastomaHumansNeoplasm Recurrence, LocalDrug Resistance, NeoplasmXenograft Model Antitumor AssaysProteomicsCell Line, TumorProto-Oncogene Proteins B-raf

Keywords

BiologyCancer researchWnt signaling pathwayGlioblastomaTemozolomideVemurafenibPhenotypeOncogeneComputational biologyTargeted therapySignal transductionBioinformaticsGeneGeneticsCell cycleCancerMelanomaSynapseRecurrenceNeuronalBrafProteogenomicsLongitudinal Glioblastoma

Sustainable Development Goals

SDG 0: Good health and well-being